Latest & greatest articles for adhd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

ADHD

ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:

  • inattentiveness
  • hyperactivity and impulsiveness

Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).

Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).

Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.

Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).

Top results for adhd

81. The effects of acute physical activity on executive functions in children with ADHD: a systematic literature review

The effects of acute physical activity on executive functions in children with ADHD: a systematic literature review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

82. Meta-analysis of the effects of pharmacological treatment on executive functioning in patients with attention deficit/hyperactivity disorder (ADHD)

Meta-analysis of the effects of pharmacological treatment on executive functioning in patients with attention deficit/hyperactivity disorder (ADHD) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2017 PROSPERO

83. Pragmatic language impairments and attention deficit hyperactivity disorder (ADHD): a systematic review

Pragmatic language impairments and attention deficit hyperactivity disorder (ADHD): a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2017 PROSPERO

84. Impact of SLC6A3 polymorphism on treatment response in child patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review and meta-analysis

Impact of SLC6A3 polymorphism on treatment response in child patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2017 PROSPERO

85. Prenatal exposure to acetaminophen and child neurodevelopment: Risk for attention deficit disorder (ADHD), hyperkinetic disorder (HKD) and autism: a systematic review with meta-analysis

Prenatal exposure to acetaminophen and child neurodevelopment: Risk for attention deficit disorder (ADHD), hyperkinetic disorder (HKD) and autism: a systematic review with meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2017 PROSPERO

86. Medications for attention deficit hyperactivity disorder (ADHD) in children

Medications for attention deficit hyperactivity disorder (ADHD) in children

2017 DynaMed Plus

87. Attention deficit hyperactivity disorder (ADHD) in children and adolescents

Attention deficit hyperactivity disorder (ADHD) in children and adolescents

2017 DynaMed Plus

90. A systematic review of the effectiveness of motor interventions for ADHD

A systematic review of the effectiveness of motor interventions for ADHD Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2017 PROSPERO

91. Bupropion for Attention Deficit Hyperactivity Disorder (ADHD) in adults [Cochrane protocol]

Bupropion for Attention Deficit Hyperactivity Disorder (ADHD) in adults [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2017 PROSPERO

92. Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: a systematic review

Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2017 PROSPERO

93. Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review

Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review Article Text Clinical reviews Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review Free Franco De

Full Text available with Trip Pro

2017 Evidence-Based Mental Health

94. Effect of chronic physical activity on symptom severity and functional impairment of children with ADHD and Disruptive Behavior Disorders: a systematic review and meta-analysis

Effect of chronic physical activity on symptom severity and functional impairment of children with ADHD and Disruptive Behavior Disorders: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2017 PROSPERO

95. Causes and risk factors: Childhood comorbidity and parental mental health problems appear to be associated with ADHD persistence

Causes and risk factors: Childhood comorbidity and parental mental health problems appear to be associated with ADHD persistence Childhood comorbidity and parental mental health problems appear to be associated with ADHD persistence | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Childhood comorbidity and parental mental health problems appear to be associated with ADHD persistence Article Text Electronic pages Causes and risk

2017 Evidence-Based Mental Health

96. Risk of unintentional injuries in ADHD children and adolescents and the impact of medication: protocol for a systematic review and meta-analysis

Risk of unintentional injuries in ADHD children and adolescents and the impact of medication: protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2017 PROSPERO

97. Facilitators and barriers to understanding of ADHD in Primary Care: a mixed-method systematic review.

Facilitators and barriers to understanding of ADHD in Primary Care: a mixed-method systematic review. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2017 PROSPERO

98. Adolescent experiences of ADHD: a systematic review and thematic synthesis of the qualitative literature

Adolescent experiences of ADHD: a systematic review and thematic synthesis of the qualitative literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2017 PROSPERO

99. What is the effectiveness of technology for managing the difficulties associated with ADHD in children and young people?

What is the effectiveness of technology for managing the difficulties associated with ADHD in children and young people? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

100. Vitamin levels in adults with ADHD (PubMed)

Vitamin levels in adults with ADHD Micronutrients containing vitamins are reported to reduce symptom levels in persons with attention-deficit hyperactivity disorder (ADHD), but data on vitamin levels in ADHD are sparse.To examine the relationship between vitamin concentrations, ADHD diagnosis and psychiatric symptoms in young adult ADHD patients and controls.Eight vitamins and the nicotine metabolite cotinine were analysed in serum samples from 133 ADHD patients and 131 controls aged between 18 (...) and 40, who also reported ADHD symptoms and comorbid conditions.Lower concentrations of vitamins B2, B6 and B9 were associated with the ADHD diagnosis, and B2 and B6 also with symptom severity. Smokers had lower levels of vitamins B2 and B9.ADHD patients were overrepresented in the group with low levels of some vitamins, possibly indicative of inadequate dietary intake of these micronutrients in a subgroup of patients. It is important to identify these patients in dietary intervention trials

Full Text available with Trip Pro

2016 BJPsych open